From the discovery of vascular endothelial growth factor to the introduction of avastin in clinical trials - an interview with Napoleone Ferrara by Domenico Ribatti.

The International journal of developmental biology

Volumn 55, Issue 4-5, 2011, Pages 383-388

  Ferrara, Napoleone ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; ARTICLE; CLINICAL TRIAL (TOPIC); DRUG ANTAGONISM; GENETICS; HISTORY; HUMAN; INTERVIEW; ITALY; MOLECULAR CLONING; NEOPLASM; PHYSIOLOGY; UNITED STATES; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL; CLINICAL TRIALS AS TOPIC; CLONING, MOLECULAR; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; ITALY; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; SAN FRANCISCO; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80155192621     PISSN: None     EISSN: 16963547     Source Type: Journal    
DOI: None     Document Type: Article

References (0)